Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Sponsors › Genomics: Clinical Implementation › Biocartis Receives FDA Clearance for Viral Detection Panel

Biocartis Receives FDA Clearance for Viral Detection Panel

Sep 05, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Biocartis announced today that its Idylla Respiratory Panel (IFV-RSV) has been granted 510(k) clearance by the US Food and Drug Administration. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Infectious Disease

  1. BD Gets CE-IVD Mark for Point-of-Care Coronavirus Antigen Test

  2. NIH Awards $234M to Boost COVID-19 Testing for Underserved Populations

  3. US to Distribute 150 Million Abbott SARS-CoV-2 Antigen Tests at No Cost

  4. BARDA Exercises $10.5M Option on T2 Bio Contract

  5. FDA Grants Emergency Use Authorizations to DiaSorin, NanoEntek, Nirmidas Coronavirus Antibody Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.